[1] Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation[J] . Diabet Med,1998,15(7):539-553.DOI:10.1002/(SICI) 1096-9136 (199807) 15:7 <539:AID-DIA668>3.0.CO;2-S.
[2] World Health Orgnization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation, 2006[M] . Geneva: WHO Document Production Services, 2006.
[3] World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia; report of a WHO/IDF consultation. Geneva(Switzerland): World Health Organization; 2006. p. 1-50..
[4] Pan XR, Yang WY, Li GW, Liu J. Prevalence of diabetes and its risk factors in China, 1994. National Diabetes Prevention and Control Cooperative Group. Diabetes Care. 1997;20(11):1664-1669. doi:10.2337/diacare.20.11.1664
[5] Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China [J] . N Engl J Med, 2010, 362(12): 1090-1011.
[6] Wang L, Gao P, Zhang M, et al. Prevalence and Ethnic Pattern of Diabetes and Prediabetes in China in 2013[J] . Jama, 2017, 317(24): 2515.DOI:10.1001/jama.2017.7596
[7] Kelly T, Yang W, Chen CS, et al. Global burden of obesity in 2005 and projections to 2030[J]. Int J Obes(Lond), 2008, 32(9):1431-1437.
[8] NRF C. Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 populationbased measurement studies with 19.2 million participants[J] . Lancet, 2016, 387: 1377-1396.
[9] Will JC, Galuska DA, Ford ES, et al. Cigarette smoking and diabetes mellitus: evidence of a positive association from a large prospective cohort study[J] . Int J Epidemiol, 2001, 30(3): 540-546.
[10] Lillioja S, Bogardus C. Obesity and insulin resistance: lessons learned from the Pima Indians[J]. Diabetes Metab Rev, 1988, 4(5): 517-540.
[11] Haire -Joshu D, Glasgow RE, Tibbs TL. Smoking and diabetes[J] .Diabetes Care, 1999, 22(11): 1887-1898.
[12] Chen C, Lu FC. Department of Disease Control Ministry of Health, PR China. The guidelines for prevention and control of overweight and obesity in Chinese adults. Biomed Environ Sci. 2004;17 Suppl:1-36.
[13] Wang H, Shara NM, Calhoun D, et al. Incidence rates and predictors of diabetes in those with prediabetes: the Strong Heart Study. Diabetes Metab Res Rev 2010;26:378–85.
[14] Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J. Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2007;298(22):2654-2664. doi:10.1001/jama.298.22.2654.
[15] Janzon L, Berntorp K, Hanson M, Lindell SE,Trell E. Glucose tolerance and smoking: a population study of oral and intravenous glucose tolerance tests in middle-aged men.Diabetologia 1983;25:86–88
[16] Facchini FS, Hollenbeck CB, Jeppesen J, Chen YD, Reaven GM. Insulin resistance and cigarette smoking. Lancet 1992;339:1128–1130
[17] Travier N, Agudo A, May AM, et al. Longitudinal changes in weight in relation to smoking cessation in participants of the EPIC-PANACEA study. Prev Med. 2012;54(3-4):183‐192. doi:10.1016/j.ypmed.2011.09.003
[18] Nagaya T,Yoshida H,Takahashi H.Heavy smoking raises risk for type 2 diabetes mellitus in obese men; but, light smoking reduces the risk in lean men: a follow-up study in Japan.Ann Epidemiol 2008;18:113-118.DOI:10.1016/j.annepidem.2007.07.107
[19] Luo W,Guo Z,Wu M,et al.Interaction of smoking and obesity on type 2 diabetes risk in a Chinese cohort.Physiol Behav 2015;139:240-243.DOI:10.1016/j.physbeh.2014.11.038
[20] Harris KK, Zopey M, Friedman TC. Metabolic effects of smoking cessation. Nat Rev Endocrinol. 2016;12(5):299–308. Acomprehensive review paper on the impact of smoking cessation on various metabolic pathways.
[21] Canoy D, Wareham N, Luben R, Welch A, Bingham S, Day N,et al. Cigarette smoking and fat distribution in 21,828 British men and women: a population-based study. Obesity Res. 2005;13(8): 1466–75.
[22] Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest.2000;106(4):473–81.
[23] Cryer PE, Haymond MW, Santiago JV, Shah SD. Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N Engl J Med. 1976;295(11):573‐577. doi:10.1056/NEJM197609092951101
[24] Kolterman OG, Insel J, Saekow M, Olefsky JM. Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects. J Clin Invest. 1980;65(6):1272‐1284. doi:10.1172/JCI109790
[25] Arner P, Rydén M. Fatty Acids, Obesity and Insulin Resistance. Obes Facts. 2015;8(2):147‐155. doi:10.1159/000381224
[26] Facchini F, Hollenbeck CB, Jeppesen J, Chen Y-DI, Reaven GM. Insulin resistance and cigarette smoking. Lancet 1992;339:1128–30.
[27] Targher G, Alberiche M, Zenere MB, Bonadonna RC, Muggeo M, Bonora E. Cigarette smoking and insulin resistance in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1997;82(11):3619-3624. doi:10.1210/jcem.82.11.4351
[28] Bajaj M. Nicotine and insulin resistance: when the smoke clears. Diabetes. 2012;61(12):3078–80.
[29] Chang SA. Smoking and type 2 diabetes mellitus. Diabetes Metab J. 2012;36(6):399–403.
[30] Kamimura D,Cain LR,Mentz RJ,et al.Cigarette Smoking and Incident Heart Failure: Insights From the Jackson Heart Study.Circulation 2018;137:2572-2582.DOI:10.1161/CIRCULATIONAHA.117.031912
[31] Heilbronn LK, Gan SK, Turner N, Campbell LV, Chisholm DJ. Markers of mitochondrial biogenesis and metabolism are lower in overweight and obese insulin-resistant subjects. J Clin Endocrinol Metab. 2007;92(4):1467‐1473. doi:10.1210/jc.2006-2210
[32] Ritov VB, Menshikova EV, He J, Ferrell RE, Goodpaster BH, Kelley DE. Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes. Diabetes. 2005;54(1):8‐14. doi:10.2337/diabetes.54.1.8
[33] Pradhan, A. D. (2001). C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus. JAMA, 286(3), 327. doi:10.1001/jama.286.3.327
[34] Mohamed-Ali V, Goodrick S, Rawesh A. et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-α, in vivo. J Clin Endocrinol Metab.1997;82:4196-4200.
[35] Banks RE, Forbes MA, Storr M. et al. The acute phase response in patients receiving subcutaneous IL-6. Clin Exp Immunol.1995;102:217-223.
[36] Papanicolaou DA, Wilder RL, Manolagas SC, Chrousos GP. et al. The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med.1998;128:127-137.
[37] Visser, M. (1999). Elevated C-Reactive Protein Levels in Overweight and Obese Adults. JAMA, 282(22), 2131. doi:10.1001/jama.282.22.2131
[38] Wannamethee, S. G., Lowe, G. D. O., Shaper, A. G., Rumley, A., Lennon, L., & Whincup, P. H. (2005). Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease. European Heart Journal, 26(17), 1765–1773. doi:10.1093/eurheartj/ehi183
[39] Spijkerman AMW, Daphne L, van der A, Nilsson PM, et al. Smoking and long-term risk of type 2 diabetes: the EPIC-InterAct study in European populations[J] . Diabetes Care, 2014, 37(12): 3164-3171.
[40] Wang C, Wang Y, Wu J, et al. Current Smoking Dose-Dependently Associated with Decreased β-Cell Function in Chinese Men without Diabetes. J Diabetes Res. 2015;2015:841768. doi:10.1155/2015/841768
[41] Hu, F. B. (2003). Television Watching and Other Sedentary Behaviors in Relation to Risk of Obesity and Type 2 Diabetes Mellitus in Women. JAMA, 289(14), 1785. doi:10.1001/jama.289.14.1785